Tumor Markers: Can They Screen for Cancer? What a High Result Means
A slightly high tumor marker on a checkup can mean sleepless nights, yet most turn out not to be cancer. Here's what these tests can and can't tell you.


Key points
- Tumor markers are useful for monitoring treatment, watching for recurrence and supporting diagnosis once there are symptoms or a lump, not for screening healthy people.
- Many non-cancer causes raise them (smoking, inflammation, liver disease, periods), and many early cancers don't raise them at all; large trials found no reduction in deaths from screening with CA-125.
- If a result is high, don't panic: review it with a doctor alongside your history, perhaps retest in 4–8 weeks, and use evidence-based screening instead.
A patient once walked in looking worried, holding a checkup report with a CEA level slightly above normal. He hadn't slept for several nights. In the end, further tests found no cancer; the cause was probably his smoking. This happens very often, so in this article I want to explain clearly what tumor markers can do and what they can't.
What are tumor markers?
Tumor markers are substances made by cancer cells, or by the body in response to cancer, that can be measured in blood, urine or other body fluids. The problem is that normal cells can make these substances too, and many early-stage cancers don't raise the levels at all.
What tumor markers are genuinely useful for
- Monitoring treatment in patients already diagnosed with cancer, to see whether treatment is working
- Watching for recurrence after surgery or completed treatment
- Supporting a diagnosis once there are symptoms or a lump, such as an ovarian mass or a liver lump
- Assessing prognosis in some cancers, such as testicular cancer
Why they aren't recommended for screening people without symptoms
| Tumor marker | Related cancer | Other causes of a high level |
|---|---|---|
| CEA | Colorectal and others | Smoking, bowel inflammation, hepatitis, pneumonia, kidney failure |
| CA 19-9 | Pancreas, bile ducts | Gallstones or blocked bile ducts, pancreatitis, poorly controlled diabetes; some people never make this marker even when they have cancer |
| CA-125 | Ovary | Periods, pregnancy, endometriosis, uterine fibroids, fluid in the abdomen from cirrhosis |
| AFP | Liver, some testicular cancers | Chronic hepatitis, cirrhosis, pregnancy |
| PSA | Prostate | Enlarged prostate, prostatitis, ejaculation or cycling before the test |
Large studies, such as PLCO, which used CA-125 with ultrasound to screen for ovarian cancer, and UKCTOCS, which followed more than 200,000 women, did not find a reduction in deaths from ovarian cancer, but did lead to unnecessary surgery in women who didn't have cancer. Major organizations such as the USPSTF and the American Cancer Society therefore don't recommend CEA, CA 19-9 or CA-125 to screen the general population.
CEA
Colon
- Smoking
- Bowel, liver, lung inflammation; kidney failure
CA 19-9
Pancreas, bile ducts
- Gallstones, bile duct blockage
- Pancreatitis, poorly controlled diabetes
CA-125
Ovary
- Periods, pregnancy
- Endometriosis
AFP
Liver, testis
- Chronic hepatitis, cirrhosis
- Pregnancy
PSA
Prostate
- Enlarged or inflamed prostate
- Ejaculation or cycling before the test
USPSTF and the American Cancer Society do not recommend CEA, CA 19-9 or CA-125 to screen the general public.
Exceptions you should know
- PSA can be used to screen for prostate cancer in men aged 55–69, but the decision should be shared with a doctor, because it reduces deaths slightly at the cost of overdiagnosis and overtreatment in some men. Men taking finasteride or dutasteride have PSA levels about half of what they would otherwise be, so tell your doctor. Men on TRT have PSA monitored according to plan.
- AFP with ultrasound is used to watch for liver cancer every 6 months in people with cirrhosis or some hepatitis B carriers.
- People with high-risk genetics, such as BRCA genes, should have a specific plan from their doctor.
So what cancer screening actually works?
- Cervical cancer: HPV DNA test or Pap smear
- Colorectal cancer: fecal immunochemical test (FIT) or colonoscopy, from age 45–50
- Breast cancer: mammogram
- Lung cancer: low-dose CT in heavy smokers aged 50–80
- Anal cancer in certain high-risk groups; see Anal cancer screening
See the full table in Health checkups for working-age adults: what to test, and remember that the HPV vaccine and hepatitis B vaccine genuinely prevent cancer.
If your tumor marker result comes back high, what should you do?
- Don't panic. Most slightly high values are not cancer.
- Bring the result to a doctor with your history, such as smoking, liver disease, periods and medicines you take.
- Have an examination and discuss your symptoms, such as weight loss, changed bowel habits, abdominal pain or jaundice.
- You may retest after 4–8 weeks to see the trend.
- Do further tests as appropriate, such as ultrasound, endoscopy or CT when there is a reason, rather than everything at once.
- 1Don't panicMildly high values are mostly not cancer
- 2Doctor reviews with historySmoking, liver disease, periods, medicines
- 3Examination, symptomsWeight loss, bowel change, abdominal pain, jaundice
- 4Repeat in 4–8 weeksLook at the trend, not one value
- 5Further tests if warrantedUltrasound, endoscopy or CT as assessed by your doctor
When to see a doctor promptly
Whatever your tumor marker result, see a doctor if you have any of these: unexplained weight loss, blood in your stool or bowel habits that have changed for several weeks, a lump you can feel, coughing up blood, yellowing of the skin or eyes, chronic abdominal pain, or abnormal vaginal bleeding.
At Dr. Kris Clinic I can interpret the results you've received, explain which values are concerning and which aren't, and plan cancer screening that suits your age and risk, with referral to a specialist when needed. English-speaking consultations are available.
Want help with this? Three simple steps
Reading is a good start. When you are ready, check where you are, see how a consultation works, then book a time that suits you.
1Free 2-minute self-checkSexual-health self-check — see your result instantly and send it to the doctor if you like.Start the self-check →
2See the steps and feesIndividual from 990 THB · couple 1,590 THB · 30–60 minutes, at the clinic or online via MCS Telemedicine.How a consultation works →
3Book with the doctorPick a time online or message us on LINE. Come on your own or with your partner. Payment confirms the booking.Book online →Self-checks are a guide only and do not replace a doctor's assessment. Outcomes vary from person to person, depending on the severity of symptoms, the complexity of the problem and other factors.
Preventive health care
Plan check-ups, nutrition and supplements that fit your age and lifestyle.
Frequently asked questions
My CEA is slightly high. Do I have cancer?
Most likely not. CEA can rise from smoking, inflammation or liver disease. Have a doctor look at it together with your symptoms; you may be retested or have further tests as appropriate.
If my tumor markers are normal, does that mean I don't have cancer?
No. Many early cancers don't raise the levels, so a normal result doesn't rule out cancer. Use evidence-based screening methods.
Should I have a PSA test?
Men aged 55–69 should discuss the pros and cons with a doctor before deciding. Men with a family history or taking testosterone may need a different plan.
อ่านบทความนี้เป็นภาษาไทย
References
- Buys SS, et al. Effect of Screening on Ovarian Cancer Mortality: The PLCO Cancer Screening Randomized Controlled Trial. JAMA. 2011;305(22):2295-2303.
- Menon U, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet. 2021;397:2182-2193.
- US Preventive Services Task Force. Prostate Cancer: Screening. JAMA. 2018;319(18):1901-1913.
- Singal AG, et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922-1965.
- Duffy MJ. Tumor markers in clinical practice: a review focusing on common solid cancers. Med Princ Pract. 2013;22(1):4-11.
This article is for education and does not replace diagnosis or treatment by a doctor. If you have symptoms or concerns, please see a doctor.










